1. Jiang, Feng, Liang, Min, Huang, Xiaolu, Shi, Wenjing, Wang, Yumin. 2021. High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma. In PeerJ, 9, e11697. doi:10.7717/peerj.11697. https://pubmed.ncbi.nlm.nih.gov/34268011/
2. Jiang, Zhao-Ming, Li, Hong-Bin, Chen, Shu-Guo. . PIMREG, a Marker of Proliferation, Facilitates Aggressive Development of Cholangiocarcinoma Cells Partly Through Regulating Cell Cycle-Related Markers. In Technology in cancer research & treatment, 19, 1533033820979681. doi:10.1177/1533033820979681. https://pubmed.ncbi.nlm.nih.gov/33356974/
3. Wang, Dekang, Hu, Aili, Peng, Hao, Li, Dongbo, Zhang, Li. 2021. Tumor-promoting function of PIMREG in glioma by activating the β-catenin pathway. In 3 Biotech, 11, 380. doi:10.1007/s13205-021-02922-5. https://pubmed.ncbi.nlm.nih.gov/34458056/
4. Zhao, Wenjing, Chang, Yuanjin, Wu, Zhaoye, Sun, Chenyu, Gao, Ju. 2023. Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation. In PeerJ, 11, e15703. doi:10.7717/peerj.15703. https://pubmed.ncbi.nlm.nih.gov/37483962/
5. Tang, Cui, Qiu, Shixiong, Mou, Wenying, Xu, Jinming, Wang, Peijun. 2022. Excessive activation of HOXB13/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance. In Biochemical and biophysical research communications, 623, 81-88. doi:10.1016/j.bbrc.2022.07.066. https://pubmed.ncbi.nlm.nih.gov/35878427/
6. Wang, Yi, Zhou, Chuan, Luo, Huan, Cheng, Lulu, Yang, Yang. 2021. Prognostic implications of immune-related eight-gene signature in pediatric brain tumors. In Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 54, e10612. doi:10.1590/1414-431X2020e10612. https://pubmed.ncbi.nlm.nih.gov/34008756/
智鼠故事 
